appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Torrent Pharmaceuticals Ltd
TORNTPHARM
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Company Profile
Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products.
Brands
Brands
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Zydus Lifesciences Ltd
Dr Reddy's Laboratories Ltd
Lupin Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Pharma shares rally; Suven, Granules, Ajanta, Jubilant surge over 5%
1 month ago•Business Standard
Torrent Pharmaceuticals set to acquire KKR’s stake in JB Chemicals
1 month ago•The Hindu Businessline
Torrent Pharma Q1 Results Review- Segment Continues To Drive Growth: Centrum
1 month ago•Bloomberg Quint
Stocks in news: HUL, Vedanta, DRL, L&T, Axis Bank, Torrent Pharma and Titagarh Rail
1 month ago•Business Today
Torrent Pharma tanks 4% post Q1FY25 results; analysts update target prices
1 month ago•Business Standard
Torrent Pharma Q1FY25 results: Net profit up 21%, revenue rises 10%
1 month ago•Business Standard
Torrent Pharma Q1 Results Review - India Growth Picking-Up Pace: ICICI Securities
1 month ago•Bloomberg Quint
Hot stocks: Brokerage view on HUL, Zensar Tech, Kajaria Ceramics, Torrent Pharma, ICICI Pru and Bajaj Finance
1 month ago•Economic Times
Stock Alert: Bajaj Finance, Hindustan Unilever, Torrent Pharma, Schaeffler India, ICICI Securities,
1 month ago•Business Standard
Stocks in news: L&T, Axis Bank, HUL, Bajaj Finance, Tata Consumer
1 month ago•Economic Times
Recent EventsAll events
Loss/Duplicate-Share Certificate-XBRL
Cash Dividend
Final • Div/Share: ₹ 6
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant